Trial intelligence / Profile preview

Articaine + Hyaluronidase vs IANB for Mandibular Molar Extraction

NCT06980363Phase 1Not yet recruiting

Sponsor
Fayoum University
Start
Jun 2025
Primary completion
Aug 2025
Modality
Therapeutic Enzymes
01

Overview

Phase 1, randomised, single-blind trial of hyaluronidase in procedural pain (2 arms), sponsored by Fayoum University. Primary endpoint: Visual Analogue Scale. Planned start Jun 2025; status: not yet recruiting.

02

Drugs

hyaluronidase
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT06980363.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06980363.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call